Fevia Constipation Control Capsule, Liquid Filled
Product Images NDC 82706-029

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fevia Constipation Control (NDC 82706-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vivunt Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp1 (Editable Box Fevia Docusate Sodium 100 mg X 50 Softgels (2) 001)

Pdp1 (Editable   Box Fevia Docusate Sodium 100 mg X 50 Softgels (2) 001)
This is a product label for a medication used for constipation control. The active ingredient is Docusate Sodium 100 mg, which acts as a stool softener laxative. It is indicated for relief of occasional constipation and irregularity, typically resulting in bowel movement within 12 to 72 hours. The label includes directions for use, warnings, and information on inactive ingredients. The product is distributed by VIVUNT PHARMA LLC and originated in India. The label also includes contact information for immediate help in case of overdose. It is recommended to consult a doctor before use if experiencing certain symptoms or conditions.*
FDA Label Image

Box (Editable Label Fevia Docusate Sodium 100 mg X 50 Softgels (3) 001)

Box (Editable   Label Fevia Docusate Sodium 100 mg X 50 Softgels (3) 001)
This is a drug facts label for a stool softener containing Docusate Sodium 100 mg. It is used for the relief of occasional constipation and irregularity. The product generally produces a bowel movement within 12 to 72 hours. The label includes warnings about not using the product while taking mineral oil, unless advised by a doctor, and advises consulting a doctor before use in case of stomach pain, nausea, vomiting, or sudden changes in bowel habits lasting more than 2 weeks. Directions indicate taking the softgel with a glass of water. It provides dosage information for adults and children. The label also mentions ingredients used in the product and advises to stop use and consult a doctor if experiencing rectal bleeding or no bowel movement after using the product, or if needing to use a laxative for more than 1 week. Special precautions are mentioned for pregnant or breastfeeding individuals. The label reminds to keep the product out of reach of children and provides contact information for Poison Control in case of overdose.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.